Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (161-170 of 299) with videos related to

Pageof 30
Sort By:
Blood|August 1, 1981
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitorsL A Clavell, J M Lipton, R C Bast, et al.
Gynecologic Oncology|February 13, 2001
Regulation of invasion of epithelial ovarian cancer by transforming growth factor-betaG C Rodriguez, C Haisley, J Hurteau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicityR C Bast, R C Knapp, A K Mitchell, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell linesG C Rodríguez, M P Boente, A Berchuck, et al.
Cancer Research|March 1, 1983
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complementR C Bast, J Ritz, J M Lipton, et al.
Cell Death and Differentiation|April 29, 2014
ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7Z Lu, H Yang, M N Sutton, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Molecular approaches to prevention and detection of epithelial ovarian cancerR C Bast, C M Boyer, F J Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculatureS J Galli, R C Bast, B S Bast, et al.
Cancer Research|August 15, 1989
Elimination of malignant clonogenic breast cancer cells from human bone marrowI C Anderson, E J Shpall, D S Leslie, et al.
Pageof 30

Showing results (161-170 of 299) with videos related to

Sort By:
Pageof 30
Blood|August 1, 1981
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitorsL A Clavell, J M Lipton, R C Bast, et al.
Gynecologic Oncology|February 13, 2001
Regulation of invasion of epithelial ovarian cancer by transforming growth factor-betaG C Rodriguez, C Haisley, J Hurteau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicityR C Bast, R C Knapp, A K Mitchell, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell linesG C Rodríguez, M P Boente, A Berchuck, et al.
Cancer Research|March 1, 1983
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complementR C Bast, J Ritz, J M Lipton, et al.
Cell Death and Differentiation|April 29, 2014
ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7Z Lu, H Yang, M N Sutton, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Molecular approaches to prevention and detection of epithelial ovarian cancerR C Bast, C M Boyer, F J Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculatureS J Galli, R C Bast, B S Bast, et al.
Cancer Research|August 15, 1989
Elimination of malignant clonogenic breast cancer cells from human bone marrowI C Anderson, E J Shpall, D S Leslie, et al.
Pageof 30